主记录
Lirafugratinib
- CAS
- 2549174-42-5
- PubChem CID
- 155309155
- SMILES
- CC1=NC(=NC=C1)OC2=C(C=C(C=C2)C3=C(N(C4=NC=NC(=C34)N)C)C5=CC=C(C=C5)NC(=O)C(=C)C)F
- 分子式
- C28H24FN7O2
- 分子量
- 509.545
- 精确分子量
- 509.1976
- InChI
- InChI=1S/C28H24FN7O2/c1-15(2)27(37)35-19-8-5-17(6-9-19)24-22(23-25(30)32-14-33-26(23)36(24)4)18-7-10-21(20(29)13-18)38-28-31-12-11-16(3)34-28/h5-14H,1H2,2-4H3,(H,35,37)(H2,30,32,33)
- InChIKey
- XOQVZSSDIQQUGO-UHFFFAOYSA-N
- LogP
- 5.4289
- TPSA
- 120.84
名称与别名
- Lirafugratinib
- FGFR2-IN-3
- Lirafugratinib?
- RLY-4008
- Lirafugratinib [USAN]
- 7HY6IMH87S
- lirafugratinib [INN]
- 2549174-42-5
- Lirafugratinib (USAN)
- RLY4008
- UNII-7HY6IMH87S
- RefChem:153645
- Rly 4008
- FGFR2 Inhibitor RLY-4008
- orb1689788
- CHEMBL5314555
- SCHEMBL22676186
- SCHEMBL30303579
- GTPL12370
- RLY 4008 [WHO-DD]
- WHO 12482
- BDBM623324
- GLXC-27490
- EX-A6478
- NSC842116
- US11780845, Example 343
- AKOS040758932
- AT44017
- EBC-515468
- example 343 [WO2020231990A1]